Nomura Holdings
KNSA icon

Nomura Holdings’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Nomura Holdings’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.3M Sell
270,724
-72,215
-21% -$3.75M 0.02% 396
2026
Q1 		$16.5M Sell
342,939
-69,700
-17% -$3.09M 0.04% 297
2025
Q4 		$17M Buy
412,639
+15,500
+4% +$622K 0.02% 360
2025
Q3 		$15.4M Buy
+397,139
New +$12.9M 0.02% 382

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Nomura Holdings's KNSA Position: Q2 2026 in Review

Nomura Holdings reduced its Kiniksa Pharmaceuticals (KNSA) stake by 21% in Q2 2026, selling an estimated $3.75M and leaving 270,724 shares worth $17.3M. The position accounts for 0.02% of the portfolio, ranked #396.

Nomura Holdings first reported a position in KNSA in Q3 2025 and has held it in 4 quarters since. 267 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • Nomura Holdings held 270,724 shares of Kiniksa Pharmaceuticals worth $17.3M as of Q2 2026.
  • Nomura Holdings sold 72,215 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $3.75M.
  • Kiniksa Pharmaceuticals made up 0.02% of Nomura Holdings's portfolio in Q2 2026, its #396 holding.
  • Nomura Holdings first reported a position in Kiniksa Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 267 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.